Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Aug. 03, 2013	Jul. 28, 2012
Cash flows from operating activities:
Net loss	$ (21,165)	$ (31,637)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred financing costs	449	449
Depreciation and amortization	6,490	6,647
Provision for losses on accounts receivable	177	93
Share-based compensation expense	207	4,419
Change in operating assets and liabilities net of effect of acquisition:
Accounts receivable	(4,938)	9,692
Inventories	(18,505)	(13,515)
Prepaid expenses and other assets	9,995	2,442
Accounts payable	15,719	10,836
Accounts payable-affiliates	830	(1,405)
Accrued expenses and other liabilities and other long-term liabilities	(2,184)	(1,609)
Net cash used in operating activities	(12,925)	(13,588)
Cash flows from investing activities:
Additions to property and equipment	(2,400)	(3,257)
Payment to acquire Parlux, net of Parlux cash on hand of $17,114	0	(44,949)
Net cash used in investing activities	(2,400)	(48,206)
Cash flows from financing activities:
Net borrowings under bank line of credit	14,472	32,142
Borrowings under affiliated notes payable to fund Parlux acquisition	0	30,000
Principal payments under capital lease obligations	(404)	(575)
Proceeds from exercise of stock options	36	46
Net cash provided by financing activities	14,104	61,613
Net decrease in cash and cash equivalents	(1,221)	(181)
Cash and cash equivalents at beginning of period	2,447	1,682
Cash and cash equivalents at end of period	1,226	1,501
Supplemental Information:
Cash paid during the period for Interest	1,436	868
Cash paid during the period for Income taxes	11	68
Fair value of equity consideration given to acquire Parlux	$ 0	$ 89,307